Sotagliflozin(1) is an oral inhibitor of sodium-dependent glucose transporters 1 and 2(SGLT-l and SGLT-2), which is clinically used to treat diabetes mellitus. The chemical structure of 1 is composed of one sugar moiety with five chiral centers, one aryl hydrophobic fragment and one methyl sulfide group. According to the analysis of reverse synthesis, the synthesis of 1 is focused on three key points: ①the construction of chiral center; ②coupling of aryl fragments with sugar groups; ③introduction of the methylthio group. Based on the construction of glycosyl chiral centers, herein the synthetic routes of 1 are summarized from the different starting materials for the construction of glycosyl chiral centers. Five synthetic routes using L-xylose as the starting material, one route with using L-glucose, and one route with dapagliflozin acetate as the starting material are reviewed and discussed, which provides some references for the researches on the synthesis.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |